
Researchers have used artificial intelligence to train algorithms to predict tumour sensitivity to systemic cancer therapies. Radiologists previously determined if …

Biofrontera AG has announced the European Commission has approved the use of their drug Ameluz in combination with photodynamic therapy …
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes

